Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY37.00 CNY
Change Today 0.00 / 0.00%
Volume 0.0
As of 2:00 AM 02/17/15 All times are local (Market data is delayed by at least 15 minutes).

nantong jinghua pharmaceu-a (002349) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/12/15 - CNY39.39
52 Week Low
04/29/14 - CNY14.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANTONG JINGHUA PHARMACEU-A (002349)

Related News

No related news articles were found.

nantong jinghua pharmaceu-a (002349) Related Businessweek News

No Related Businessweek News Found

nantong jinghua pharmaceu-a (002349) Details

Nantong Jinghua Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products primarily in China. The company offers its products in the forms of injections, tablets, capsules, granules, pills, powders, and syrups. It provides APIs, intermediates, western medicines, and Chinese traditional medicines, as well as special recommended processing products. The company was founded in 1957 and is based in Nantong, China.

Founded in 1957

nantong jinghua pharmaceu-a (002349) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nantong jinghua pharmaceu-a (002349) Key Developments

Nantong Jinghua Pharmaceutical Co., Ltd., 2014 Earnings Call, Feb 27, 2015

Nantong Jinghua Pharmaceutical Co., Ltd., 2014 Earnings Call, Feb 27, 2015

Nantong Jinghua Pharmaceutical Co., Ltd., Annual General Meeting, Mar 10, 2015

Nantong Jinghua Pharmaceutical Co., Ltd., Annual General Meeting, Mar 10, 2015., at 14:00 China Standard Time. Agenda: To consider 2014 work report of the Board of Directors; to consider 2014 work report of the supervisory committee; to consider 2014 inner control self-evaluation report; to consider 2014 financial resolution report; to consider 2014 profit distribution plan; to consider 2014 annual report and its summary; to consider special report on storage and use of raised funds; to consider the plan for the shareholders profit return for the next three years (2015-2017); to consider re-appointment of audit firm; to consider determination of annual remuneration for the board chairman; and to consider other issues.

Nantong Jinghua Pharmaceutical Co., Ltd. Proposes Final Dividend for 2014

Nantong Jinghua Pharmaceutical Co., Ltd. proposed final cash dividend of CNY 1.00000000 per 10 shares (tax included) for 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002349:CH CNY37.00 CNY 0.00

002349 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002349.
View Industry Companies

Industry Analysis


Industry Average

Valuation 002349 Industry Range
Price/Earnings 100.0x
Price/Sales 13.1x
Price/Book 6.9x
Price/Cash Flow 243.4x
TEV/Sales 14.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANTONG JINGHUA PHARMACEU-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at